1. Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives
   Maria Giovanna Scioli et al, 2021, International Journal of Molecular Sciences CrossRef
2. Advances in the research of osteosarcoma stem cells and its related genes
   Weifei Zhang et al, 2022, Cell Biology International CrossRef
3. Establishment of DHFR-deficient HEK293 cells for high yield of therapeutic glycoproteins
   Emmanuel Osei Mensah et al, 2019, Journal of Bioscience and Bioengineering CrossRef
4. MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma
   Adèle Mangelinck et al, 2019, Scientific Reports CrossRef
5. Quercetin potentializes the respective cytotoxic activity of gemcitabine or doxorubicin on 3D culture of AsPC-1 or HepG2 cells, through the inhibition of HIF-1α and MDR1
   Sarah Hassan et al, 2020, PLOS ONE CrossRef
6. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
   Louise Marchandet et al, 2021, Cancers CrossRef
7. Overexpression of TBL1XR1 confers tumorigenic capability and promotes recurrence of osteosarcoma
   Xinhua Xi et al, 2019, European Journal of Pharmacology CrossRef
8. ALDH1A1 as a marker for metastasis initiating cells: A mechanistic insight
   Nandini Datta et al, 2024, Experimental Cell Research CrossRef
9. The characterization of the sensitive ovarian cancer cell lines A2780 and W1 in response to ovarian CAFs
   Karolina Wojtowicz et al, 2023, Biochemical and Biophysical Research Communications CrossRef
10. In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice
    Maria Eugénia Marques da Costa et al, 2019, Cancers CrossRef
11. Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche
    Giada Bassi et al, 2020, Scientific Reports CrossRef
12. Circular PVT1: an oncogenic non-coding RNA with emerging clinical importance
    Jayashree Adhikary et al, 2019, Journal of Clinical Pathology CrossRef
13. Untargeted LC–MS/MS analysis reveals metabolomics feature of osteosarcoma stem cell response to methotrexate
    Feng Wang et al, 2020, Cancer Cell International CrossRef
14. Recent Insights into Therapy Resistance in Osteosarcoma
    Zachary D. Prudowsky et al, 2020, Cancers CrossRef
15. Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters
    Sara R. Martins-Neves et al, 2022, International Journal of Molecular Sciences CrossRef
16. LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside
    Qin Hu et al, 2022, Cell Death Discovery CrossRef
17. miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1
    Dawei Wu et al, 2019, Cancer Gene Therapy CrossRef
18. Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies
    Claudia Maria Hattinger et al, 2021, Cancers CrossRef
19. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR
    Fangchao Gong et al, 2019, European Journal of Pharmacology CrossRef
20. LncRNA EBLN3P attributes methotrexate resistance in osteosarcoma cells through miR-200a-3p/O-GlcNAc transferase pathway
    Ming-Xia Sun et al, 2022, Journal of Orthopaedic Surgery and Research CrossRef
21. Advances in drug resistance of osteosarcoma caused by pregnane X receptor
    Kunhong Mao et al, 2024, Drug Metabolism Reviews CrossRef